1 minute reading time (63 words)

New DEA Buprenorphine Guidance

The U.S. Drug Enforcement Administration (DEA) issued guidance to DEA-registered physicians providing new flexibility for physicians managing patients with opioid use disorder. The new guidance permits physicians and other health professionals with a waiver allowing them to prescribe buprenorphine for the treatment of opioid use disorder to issue these prescriptions to new and existing patients based on an evaluation via telephone. Full guidance.

Related Posts

Want more pain resources? Check out our library of on-demand education, upcoming events, and more.

Learn More